ARTICLE | Company News
Management tracks
April 2, 2015 2:06 AM UTC
Antibody-drug conjugate company ImmunoGen Inc. (NASDAQ:IMGN) hired Anna Berkenblit as VP and CMO. Berkenblit was SVP of clinical development at H3 Biomedicine Inc. (Cambridge, Mass.).
Ear disease company Otonomy Inc. (NASDAQ:OTIC) named Dean Hakanson CMO. Hakanson was VP and head of health economics and outcomes research for U.S. medical and drug regulatory affairs at Novartis AG (NYSE:NVS; SIX:NOVN). ...